[New aspects of therapy with standard immunoglobulin preparations].
Both, in vitro and in vivo studies have shown that intravenous immunoglobulin administration in high doses is of usefulness in the therapy of bacterial infections because of synergistic effects with antibiotics. Unmodified, polyvalent immunoglobulin for intravenous administration is actually used for therapy in patients with severe generalized infections, in patients with autoimmune diseases such as idiopathic thrombocytopenic purpura (ITP). ITP patients were treated with IgG i.v. 400 mg/kg KG. One can hope for practical purposes that IgG preparations administrated prophylactically decrease infectious complications in myelosuppressive phases during aggressive tumor therapy.
D000936:Antigen-Antibody Complex / Q000276:immunology; D001327:Autoimmune Diseases / Q000628:therapy; D001424:Bacterial Infections / Q000628:therapy; D003131:Combined Modality Therapy; D006561:Herpes Simplex / Q000628:therapy; D006562:Herpes Zoster / Q000628:therapy; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D008175:Lung Neoplasms / Q000628:therapy; D008297:Male; D009103:Multiple Sclerosis / Q000628:therapy; D011696:Purpura, Thrombocytopenic / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy; D013736:Testicular Neoplasms / Q000628:therapy
D000936:Antigen-Antibody Complex
Neue Aspekte der Therapie mit Standard-Immunglobulin-Präparaten.